Embil Pharmaceutical Co. Ltd.(Embil) is a privately held company. It is principally engaged in the development, manufacturing and distribution of pharmaceutical products. The company provides treatments for vaginal infections, dermatology, topical pain, hemorrhoid, epilepsy and family planning. It offers acne products, vaginitis products that includes Gynomax Vaginal Ovule, Miko-Penotran Pessary, Neo-Penotran Forte L Pessary and Neo-Penotran Pessary, analgesic and myorelaxant products such as Gamakuil tablet, suppositories, Kuilil film tablet and topical gel, antiepileptic products and contraceptive products. Embil uses Lamellar Penetration System in its products. In addition the company exports to 23 countries include East Europe and Asian countries. The company is certified by Bureau Veritas Quality International (BVQI) for the ISO 9001 : 2000 quality standard. Embil is headquartered in Istanbul, Turkey.

Street: 
Ayazaga Ticaret Merkezi No-11/1
City: 
Maslak
Postcode: 
34398
Federal State : 
Turkey
WebSite: 
www.embil.com
Fax: 
90-212-2869641

Company Index Score

Current Index Score Historical Index Score
  • Embil Pharmaceutical Co. Ltd. currently scores 50 % in the index.
  • Embil Pharmaceutical Co. Ltd. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Embil Pharmaceutical Co. Ltd. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets